Prevalence of Creatinine Phosphokinase Increase in Patients With Solid Tumors Treated by Inhibitors of Tyrosine Kinases
NCT01248429
·
clinicaltrials.gov ↗
COMPLETED
Status
154
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Solid Tumor
Interventions
BIOLOGICAL:
CPK dosage
OTHER:
Clinical exam
Sponsor
Centre Oscar Lambret